Cargando…
Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
Adrenomedullin (AM) is a bioactive peptide with various physiological functions, including vasodilation, angiogenesis, anti-inflammation, organ protection, and tissue repair. AM suppresses inflammatory cytokine production in the intestinal mucosa, improves vascular and lymphatic regeneration and fun...
Autores principales: | Ashizuka, Shinya, Kita, Toshihiro, Inatsu, Haruhiko, Kitamura, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391925/ https://www.ncbi.nlm.nih.gov/pubmed/34440272 http://dx.doi.org/10.3390/biomedicines9081068 |
Ejemplares similares
-
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series
por: Ashizuka, Shinya, et al.
Publicado: (2015) -
Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab
por: Ashizuka, Shinya, et al.
Publicado: (2019) -
Adrenomedullin Therapy in Moderate to Severe COVID-19
por: Kita, Toshihiro, et al.
Publicado: (2022) -
Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases
por: Kita, Toshihiro, et al.
Publicado: (2022) -
Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)